[Federal Register Volume 62, Number 142 (Thursday, July 24, 1997)]
[Notices]
[Page 39851]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 97-19420]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Allergy and Infectious Diseases; Notice of 
Closed Meeting

    Pursuant to Section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
National Institute of Allergy and Infectious Diseases Special Emphasis 
Panel (SEP) meeting:
    Name of SEP: Innovation Grant Program for Approaches in HIV Vaccine 
Research.
    Date: August 1, 1997.
    Time: 8:30 a.m. to Adjournment.
    Place: Bethesda Ramada Hotel, Ambassador I, 8400 Wisconsin Avenue, 
Bethesda, MD 20814, (301) 654-1000.
    Contact Person: Hortencia Hornbeak, Scientific Review Adm., 6003 
Executive Boulevard, Solar Bldg., Room 4C19, Bethesda, MD 20892, (301) 
496-2550.
    Purpose/Agenda: To evaluate grant applications.
    The meeting will be closed in accordance with the provisions set 
forth in secs. 552b(c)(4) and 552b(c)(6), Title 5, U.S.C. Applications 
and/or proposals and the discussions could reveal confidential trade 
secrets or commercial property such as patentable material and personal 
information concerning individuals associated with the applications 
and/or proposals, the disclosure of which would constitute a clearly 
unwarranted invasion of personal privacy.

(Catalog of Federal Domestic Assistance Programs Nos. 93.855, 
Immunology, Allergic and Immunologic Diseases Research; 93.856, 
Microbiology and Infectious Diseases Research, National Institutes 
of Health)

    Dated: July 16, 1997.
LaVerne Y. Stringfield,
Committee Management Officer, NIH.
[FR Doc. 97-19420 Filed 7-23-97; 8:45 am]
BILLING CODE 4140-01-M